Sanofi drops injector pen patent case against Alphapharm
Intellectual Property 2019-04-24 8:49 pm By Cat Fredenburgh | Melbourne
Please login to bookmark Close

After losing its fight for a temporary injunction, Sanofi-Aventis has dropped its patent lawsuit against Alphapharm over the generic drug maker’s plans to market a competing insulin injector pen in Australia.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?
error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au